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ABSTRACT: Fluoride exposure is widespread, with drinking water commonly containing 
natural and artificially added sources of the ion. Ingested fluoride undergoes absorption 
across the gastric and intestinal epithelia. Previous studies have reported adverse 
gastrointestinal effects with high levels of fluoride exposure. Here, we examined the effects 
of fluoride on the transepithelial ion transport and resistance of three intestinal epithelia. We 
used the Caco-2 cell line as a model of human intestinal epithelium, and rat and mouse 
colonic epithelia for purposes of comparison. Fluoride caused a concentration-dependent 
decline in forskolin-induced Cl
-
 secretion and transepithelial resistance of Caco-2 cell 
monolayers, with an IC50 for fluoride of about 3 mM for both parameters. In the presence of 5 
mM fluoride, transepithelial resistance fell exponentially with time, with a t1/2 of about 7 h. 
Subsequent imaging by immunofluorescence and scanning electron microscopy showed 
structural abnormalities in Caco-2 cell monolayers exposed to fluoride. The Young’s 
modulus of the epithelium was not affected by fluoride, although proteomic analysis revealed 
changes in expression of a number of proteins, particularly those involved in cell-cell 
adhesion. In line with its effects on Caco-2 cell monolayers, fluoride, at 5 mM, also had 
profound effects on Cl
-
 secretion and transepithelial resistance of both rat and mouse colonic 
epithelia. Our results show that treatment with fluoride has major effects on the structure, 
function, and proteome of intestinal epithelia, but only at concentrations considerably higher 
than those likely to be encountered in vivo, when much lower fluoride doses are normally 
ingested on a chronic basis. 
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INTRODUCTION 
Fluoride exposure is common worldwide. The anion occurs naturally and is also commonly 
added to drinking water, with current World Health Organization guidelines (2006) 
recommending levels of 1.5 mg/L. Dental caries is a significant healthcare problem, 
occurring in 46% of 15 year-olds in the UK, for example (Murray et al., 2015), and fluoride 
is widely known for its beneficial effects in combating this condition (Parnell et al., 2009). 
Inadequate levels of exposure to fluoride (<0.5 mg/L in drinking water) can result in 
increased predisposition to caries, while excessive intake is associated with dental, and at 
higher levels, skeletal, fluorosis (McDonagh et al., 2000). Although, water is often the 
predominant source of intake, dental hygiene products, food and teas can also contribute to 
fluoride ingestion (Fawell et al., 2006). Importantly, levels of fluoride exposure are 
inconsistent worldwide, with many countries such as India and China reporting endemic 
fluorosis (Jolly et al., 1969; Lyth, 1946) as a result of naturally elevated levels in drinking 
water. 
Ingested fluoride undergoes rapid gastric absorption in a pH-dependent manner, as a 
result of the high lipid solubility of hydrogen fluoride (Gutknecht and Walter, 1981), and 
increasing acidity increases the rate of uptake (Whitford and Pashley, 1984). Other factors, 
such as recent food consumption or dietary calcium consumption, can limit fluoride 
absorption (Whitford, 1994). The remaining fluoride is mostly absorbed in the small intestine 
(Nopakun et al., 1989), with a rate independent of pH (Buzalaf and Whitford, 2011). 
Gastrointestinal toxicity has been observed with fluoride, and gastrointestinal symptoms have 
been reported in cases of skeletal fluorosis (Dasarathy et al., 1996). Chronic ingestion of 
fluoride has also been correlated with histologically observable damage to the gastric 
epithelium (Das et al., 1994). These studies, although small-scale, indicate that further study 
of the potential adverse effects of fluoride on the gastrointestinal tract is warranted.  
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The intestinal epithelium is highly specialized, with distinct apical and basolateral 
transporters, and this functional polarization facilitates a broad range of absorptive and 
secretory functions (Cuthbert et al., 1999). Na
+
 acts as the lead ion for absorption, with the 
Na
+
/K
+
-ATPase producing an inward electrochemical gradient for Na
+
. This gradient enables 
diffusion of Na
+
 into the cell through epithelial Na
+
 channels, which is accompanied by Cl
-
 
and water movement. The Na-K-Cl co-transporter (NKCC1) moves Cl
-
 ions into the cell via 
secondary active transport, coupled with Na
+
 and K
+
. K
+
 then passes through basolateral K
+
 
channels, which hyperpolarizes the cell, thereby increasing the driving force for Cl
-
 exit. Cl
-
 
secretion through apical Ca
2+
-activated chloride channels and the cystic fibrosis 
transmembrane conductance regulator (CFTR) is accompanied by Na
+
 and water (Barrett and 
Keely, 2000). Elevations of intracellular cAMP promote secretory mechanisms by actions on 
CFTR, NKCC1 and the basolateral KvLQT1 K
+
 channel (Cuthbert et al., 1999).  
Tight junctions between gastrointestinal epithelial cells form a continuous barrier 
between apical and basolateral cell surfaces, and control transport via the paracellular 
pathway (Balda et al., 1992). Tight junctions determine the integrity and core physiological 
properties of epithelia, such as the nature of molecules and ions that can diffuse across. Their 
regulation allows these epithelial properties to undergo dynamic changes (Matter and Balda, 
2003). Tight junction complexes are composed of three key components: integral proteins, 
such as zona occludens-1 (ZO-1), that traverse the intercellular space, plaque proteins that 
join the integral proteins to the cytoskeleton, and a diverse range of multifunctional 
nuclear/cytosolic proteins (Schneeberger and Lynch, 2004). The ‘tightness’ or permeability 
of these junctions to ions is often measured via transepithelial resistance (Rt). As a result of 
the need for extensive absorption and secretion, the gastrointestinal tract has a relatively low 
Rt, with the exception of the terminal colonic regions (Anderson and Van Itallie, 2009).  
 5 
The concentrations of fluoride required to produce toxic effects on the gastrointestinal 
tract, and importantly whether such concentrations are reached in vivo, are unclear. Here, we 
studied the effects of fluoride on the structure, function, and proteome of a model colonic 
epithelial cell line, the human Caco-2 cell line, and also on transepithelial ion transport in rat 
and mouse colonic epithelia. We observed profound structural and functional effects of 
fluoride; however, these effects were produced at fluoride concentrations that are unlikely to 
be encountered in vivo. 
 
MATERIALS AND METHODS 
Cell Culture 
Caco-2 cells were cultured in Dulbecco’s Modified Eagle’s Medium (Life Technologies), 
containing 10% fetal bovine serum, 1% penicillin and 1% streptomycin at 37°C in an 
atmosphere of 5% CO2/95% air. For polarized monolayer formation, cells were seeded into 
Snapwell™ inserts (Corning), which contained a 12-mm diameter polycarbonate membrane 
with 0.4-µm diameter pores. Inserts were placed in 6-well plates with 1.5 mL and 4 mL of 
medium on the apical and basolateral sides of the monolayers, respectively. Cells were 
cultured for 14-16 days to allow the formation of a tight, polarized epithelium. Note that 
although the Caco-2 cell line was originally derived from a human colon adenocarcinoma, 
the characteristics of the cells in culture depend heavily on culture conditions and are often 
more similar to those of small intestinal enterocytes (Sambuy et al., 2005). For this reason, 
we regard the Caco-2 cell monolayers as a model of a human intestinal epithelium in general, 
rather than of a colonic epithelium in particular. 
 
Preparation of Rat and Mouse Colonic Epithelia  
Wild type rats and mice of mixed weight, age and sex were used to provide sections of 
colonic tissue. Following cervical dislocation, the peritoneum was dissected away; the colon 
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was removed and the tissue was maintained in aerated (5% CO2/95% O2) Krebs-Henseleit 
solution (117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 
24.8 mM NaHCO3, 11.1 mM glucose, pH 7.4). The section of colon below the caecum was 
divided into three or four 1.5-cm segments, which were incised along the mesenteric line. 
The serosa and muscularis mucosae were then removed using watchmaker’s forceps. 
 
Measurement of Transepithelial Ion Transport and Resistance 
Voltage clamps (DVC-1000 Epithelial Voltage/Current Clamp, World Precision Instruments) 
were calibrated before each experiment (Input/Offset and Fluid RES compensation set to 0.0). 
Snapwell™ inserts with confluent Caco-2 cell monolayers were transferred to Ussing 
chambers (Ussing and Zerahn, 1951) with a 1.13 cm
2 
aperture (World Precision Instruments). 
For colonic epithelia, the aperture was 0.2 cm
2
. The monolayers or epithelia were bathed on 
both apical and basolateral sides with 20 mL of Krebs-Henseleit solution at 37°C, and 
continuously aerated with 5% CO2/95% O2. Chambers were left for 10-30 min to equilibrate 
once voltage clamping had begun. PowerLab 2/25 software (ADInstruments) was used to 
record the short-circuit current (Isc) across the epithelium, with one data point per second 
plotted on continuous axes of Isc versus time. All traces were recorded using PowerLab 
hardware with LabChart software, and data were analysed using Microsoft Excel software. 
Transepithelial resistance (Rt) was measured via changes in Isc during 5-s pulses to a 2-mV 
transepithelial voltage every 30 s, according to Ohm’s law, (Rt=V/I). 3-isobutyl-1-
methylxanthine (IBMX; Sigma), amiloride (Sigma) and furosemide (Sigma) were dissolved 
in water, while forskolin (Calbiochem) was dissolved in 95% ethanol. Drugs were diluted to 
appropriate final concentrations in Krebs-Henseleit solution. 
 
Data Analysis 
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All traces were viewed on a LabChart Reader, and data were recorded in a Microsoft Excel 
2013 spreadsheet for further analysis. For all data, mean and standard error of the mean 
(SEM) were calculated. 
 Concentration-response curves for the effects of fluoride or forskolin on ΔIsc and for the 
effect of fluoride on Rt were plotted in Excel 2013.  Data were fitted to the following 4-
parameter logistic equation using the maximum likelihood approach: 
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where E is the response (ΔIsc or Rt), [A] is [NaF] or [forskolin], Min is the response when 
[A]=0, Max is the response when [A]=, pIC50=-log(IC50),and nH is the Hill Coefficient. 
 For these data an additional model was used for the residual error variance (RUV): 
 ii yRUV ˆ
2  
where RUVi is the residual unexplained variance for data point I, 
2
 is a variance parameter, 
and  i is the modeled response for data point i.  defines the relationship between residual 
error and response; e.g. when  = 0, residual error is constant (i.e. homoscedastic) and when  
= 2, the standard deviation of the residual error is directly proportional to the response (i.e. 
the coefficient of variation is a constant). 
 
 The Excel Solver function was used to minimize the value of extended least squares to fit 
the curves, integrating both of the above models. GraphPad Prism 6 or 7 was used to plot 
exponential decline curves of Rt and ΔIsc in time-course experiments, to carry out linear 
regression and to compare data sets with unpaired t-tests. Two-way ANOVA tests with 
Bonferroni’s post-hoc tests were used to compare the difference in means between control 
and fluoride exposure data for experiments on colonic epithelia. One-way ANOVA tests with 
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Tukey’s post-hoc tests were used to determine how means changed during each protocol. 
Significance was taken at P<0.05. 
 
Scanning Electron Microscopy 
Cell monolayers on polycarbonate membranes (excised from Snapwell™ inserts) and 
supported on coverslips were quench-frozen by plunging, cell face first, into melting propane 
cooled in liquid nitrogen. Monolayers were freeze-dried in a modified Edwards 306 Auto 306 
carbon coating unit (Warley and Skepper, 2000). After drying, the cells were coated with 
carbon and attached to scanning electron microscopy stubs with colloidal silver. The cells 
were coated with 10 nm of gold in a Quorum/Emitech K575X sputter coater and viewed in an 
FEL-Philips XL30 FEGSEM at 5 kV.  
 
Immunofluorescence 
Cell monolayers were fixed in 4% paraformaldehyde in phosphate-buffered saline, and 
permeabilized by treatment with 0.05% saponin in the same buffer containing 0.2% gelatin. 
Monolayers were incubated in permeabilization buffer containing rat monoclonal anti-zona 
occludens-1 (ZO-1) monoclonal antibody (eBioscience), followed by fluorescein 
isothiocyanate-conjugated rabbit anti-rat secondary antibody (Sigma). The cells were then 
subjected to fluorescence microscopy. 
 
Measurement of Young’s Modulus 
The stiffness of living Caco-2 epithelial cell monolayers, as represented by their Young’s 
modulus, was determined using an atomic force microscopy (AFM) nano-indentation 
technique (Heinz and Hoh, 1999; Kasas and Dietler, 2008). The Young’s modulus was 
calculated via the force that had to be exerted to indent the cell membrane by a fixed distance. 
Measurements were conducted at room temperature using a scanning probe microscope 
(BioScope
® 
I SPM, Bruker) integrated into an inverted microscope (Axiovert 135, Zeiss). 
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Cell monolayers growing in 6-well culture plates were washed with 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid- (HEPES)-buffered saline solution (135 mM NaCl, 5 mM KCl, 
1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, pH 7.4) and bathed in the same solution during 
experiments. Measurements were performed using soft cantilevers (spring constant, <20 
pN/nm; Novascan) with a polystyrene sphere (diameter, 10 µm) as the tip. A maximal 
loading force of 10 nN was applied. For each monolayer, 9 cell areas were chosen and 25 
force-distance curves were collected for each area. AFM data were collected with NanoScope 
software 5.31 (Bruker). Young’s modulus values were calculated from force-distance curves 
using AtomicJ Software (Hermanowicz et al., 2014). Average Young’s modulus values were 
calculated for each cell area, and these values were in turn averaged to produce a single value 
for each monolayer. Four monolayers were analysed for each condition (i.e. with or without 
fluoride treatment). 
 
Proteomic Analysis of Caco-2 Cells 
Caco-2 cell monolayers were either untreated (control) or exposed to 5 mM fluoride (as NaF) 
for 24 h. Experiments were conducted in quintuplicate. Membrane proteins were extracted 
using a Mem-PER™ eukaryotic membrane protein extraction kit (Thermo Scientific). The 
fraction containing hydrophobic proteins was collected and the proteins were purified using 
detergent removal spin columns (Thermo Scientific). Proteins were extracted, reduced, 
alkylated and digested as previously described (Antonio et al., 2017), and then analyzed 
using a nanoAcquity UPLC-XEVO QToF mass spectrometry system (Lima Leite et al., 
2014). Differences in expression between the groups were assessed using PLGS software and 
expressed as P<0.05 for down-regulated and (1-P)>0.05 for up-regulated proteins. Functional 
enrichment was analysed using ClueGo, a Cytoscape plugin. For each comparison, 
bioinformatics analysis was performed, as described previously (Orchard, 2012; Bauer-
Mehren, 2013; Millan, 2013; Lima Leite et al., 2014). 
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RESULTS 
Effect of Fluoride on Caco-2 Cell Monolayers 
Caco-2 cells were cultured for 14-16 days on polycarbonate membranes to produce polarized 
monolayers, and transepithelial ion transport was measured using short circuit current (Isc) 
recordings in Ussing chambers. Addition of forskolin (10
-5
 M) to both sides of the monolayer, 
in the presence of the phosphodiesterase inhibitor IBMX (10
-4
 M), was used to elevate 
intracellular cAMP concentration. Forskolin treatment caused a transient rise in Isc (asterisk), 
through a cAMP-dependent stimulation of Cl
-
 transport via CFTR [Fig. 1(A)]. The transient 
nature of the effect of forskolin on Caco-2 monolayers has been observed previously (Zhu et 
al., 2005; Jantarajit et al., 2017) and may be a result of a lack of hyperpolarising K
+
 channels 
in the basolateral membrane, which sustain prolonged secretory responses in other epithelia 
(see below). The forskolin-stimulated Isc in untreated monolayers (transporting area 1.13 cm
2
) 
was typically about 2 A/cm2, and the transepithelial resistance was about 350 Ω cm2. 
Preincubation of the monolayers in medium containing various concentrations of fluoride for 
48 h resulted in a concentration-dependent reduction in forskolin-stimulated Isc [Fig. 1(B)], 
with an IC50 for fluoride of 3.1 mM (95% confidence interval, 2.9-3.3 mM). Transepithelial 
resistance (Rt) was also reduced in a concentration-dependent manner by fluoride treatment 
over a 48-h period [Fig. 1(C)], with an identical IC50 of 3.1 mM (95% confidence interval, 
2.6-3.7 mM). The time-course of the effect of fluoride (5 mM) on Rt was exponential, with a 
t1/2 of 7.08±2.98 h [Fig. 1(D)]. 
To probe the effect of fluoride on the fine structure of the Caco-2 cell monolayer, we 
used scanning electron microscopy. Confluent monolayers were either untreated or treated 
for 48 h with 5 mM fluoride, conditions that reduced transepithelial resistance to zero (see 
above). Typical scanning electron micrographs are shown in Fig. 2. As can be seen, the apical 
 11 
surface of the control monolayer was almost flat, although individual cells could just be 
discerned [Fig. 2(A)]. In contrast, the surface of the fluoride-treated monolayer was highly 
disrupted, with apparent gaps in the monolayer and the presence of rounded cells [Fig. 2(B)]. 
This observation suggested that the tight junctions between the cells might have been 
disrupted by fluoride treatment. To test this possibility, we examined the distribution of the 
tight junction protein ZO-1 by immunofluorescence [Fig. 3]. We found that the control 
monolayer had a regular pavement-like appearance, with polygonal staining for ZO-1 [Fig. 
3(A)]. In contrast, the fluoride-treated monolayer showed a more irregular ZO-1 staining 
pattern [Fig. 3(B)]. Further, the polygons bounded by ZO-1 were larger than in the control 
monolayer and often enclosed more than one cell, as indicated by the nuclei that were visible 
in the image (arrows). Fluoride, therefore, disrupted the tight junction arrangement in Caco-2 
cell monolayers. 
We also examined the effect of fluoride on the Young’s modulus of Caco-2 epithelia by 
nanoindentation using AFM. Cell monolayers growing in plastic culture dishes were either 
incubated with 5 mM fluoride for 48 h or left untreated. At the end of the incubation period, 
the mechanical properties of cells within the monolayers were measured using AFM probes 
with spherical tips as mechanosensors. The AFM probe was lowered onto the cell monolayer 
until it made contact with the apical membrane. It was then allowed to indent the cells for 
~300 nm, which resulted in bending of the cantilever upon which the tip is mounted. This 
bending was amplified by a laser beam projected onto the back of the cantilever, and the 
reflected beam was monitored by a split photodiode. The tip was retracted from the cell, and 
multiple cycles of indentation and retraction were carried out. A force-distance curve was 
plotted for each cycle, relating the bending of the cantilever (or the applied force) to the 
position of the sample. The Young’s modulus of each cell was then calculated from the slope 
of this curve. The values of Young’s modulus for control and fluoride-treated cells were 
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12.9±3.3 (n=4) and 21.0±3.1; (n=4) kPa, respectively (P=0.12). Hence, fluoride treatment did 
not significantly affect the Young’s modulus of the cells, as we reported recently for M-1 
mouse kidney cortical collecting duct epithelia (Antonio et al., 2017). It is noteworthy that 
the Young’s modulus of the Caco-2 cell monolayer is substantially greater than the 1 kPa 
obtained for M-1 cell monolayers, although it is similar to the value of about 25 kPa reported 
for MDCK cell monolayers (Schulze et al., 2017). 
 
Effect of Fluoride on Rat Colonic Epithelia 
As mentioned above, Caco-2 cell monolayers are not an ideal model of a colonic epithelium. 
Hence, we sought to determine the effect of fluoride on ex vivo colonic epithelia. 
Representative cumulative concentration-response results for forskolin acting on a rat colonic 
epithelium are shown in Figure 4(A). Initially, amiloride (10
-5
 M) was added to the apical 
side of the epithelium to inhibit Na
+
 entry through epithelial Na
+
 channels (ENaCs). In fact, 
amiloride did not evoke a response (arrowhead), indicating that electrogenic Na
+
 transport 
does not contribute to the Isc in this epithelium. Addition of forskolin (10
-5
 M) to both sides of 
the epithelium (asterisks) caused a long-lasting increase in Isc, in contrast to the transient 
response seen in Caco-2 cell monolayers (above). This is likely because basolateral K
+
 
channels in the native colonic epithelial cells have a greater ability to maintain a 
hyperpolarised state, and thus to maintain Cl
-
 secretion, compared with Caco-2 monolayers 
(Cuthbert et al., 1999). Forskolin caused a concentration-dependent increase in Isc, peaking at 
about 125 A/cm2 [Fig. 4(A)], far greater than the 2 A/cm2 seen in Caco-2 cell monolayers 
(above). Addition of furosemide (10
-4
 M) to the basolateral side of the epithelium at the end 
of the experiment almost abolished the forskolin-induced increase in Isc (circle), consistent 
with its action as a blocker of NKCC1. Pre-treatment of the epithelia for 30 min with 5 mM 
fluoride almost completely abolished the Isc response to forskolin [Fig. 4(B)]. In addition, the 
Isc responses to the voltage pulses grew progressively during the course of the experiment (~1 
 13 
h), indicating that Rt was falling, likely because of a continuing effect of fluoride. Combined 
data for forskolin acting on control and fluoride-treated rat colonic epithelia are shown in 
Figure 4(C). The parameters of the curve for the control epithelia were EC50=3.33 x 10
-7 
M, 
Min=-2.87 μA, Max=26.93 μA, Hill coefficient 0.95. The effect of fluoride on forskolin-
stimulated Isc was highly significant (two-way ANOVA; P<0.0001). In fact, for the fluoride-
treated tissues, forskolin did not cause a positive change in Isc. The resistance of control rat 
colonic epithelia was about 35 Ω cm2, far lower than the value for Caco-2 cell monolayers, 
and remained constant for up to 3.5 h [Fig. 4(D)]. Consistent with its effect on forskolin-
stimulated Isc, fluoride caused a dramatic reduction in Rt over a 30-min incubation period, and 
there was no significant further decrease over a subsequent 3-h incubation (one-way ANOVA 
with Tukey’s post-hoc test; P≥0.05). Rt for fluoride-treated epithelia was significantly lower 
at all time points than Rt for control epithelia (P<0.0001). 
 
Effect of Fluoride on Mouse Colonic Epithelia 
As in the rat colonic epithelia, forskolin caused a concentration-dependent increase in Isc in 
mouse colonic epithelia, rising to about 80 A/cm2 at 10-5 M forskolin [Fig. 5(A)]. Again, 
pre-treatment of the epithelia for 30 min with 5 mM fluoride almost completely abolished the 
Isc response to forskolin. The parameters of the curve for the control epithelia were 
EC50=2.71 x 10
-7 
M, Hill coefficient=2.21, and for fluoride-treated epithelia the parameters 
were EC50=2.93 x 10
-7 
M, Hill coefficient=12.08. After fluoride treatment, the maximum 
response to forskolin was reduced by 78% from 77 A/cm2 to 17 A/cm2. As with rat 
epithelia, the effect of fluoride on forskolin-stimulated Isc was highly significant (two-way 
ANOVA; P<0.0001). The resistance of control mouse colonic epithelia was about 50 Ω cm2 
(i.e. higher than that in the rat colonic epithelia), and again remained constant for up to 3.5 h 
[Fig. 5(B)]. Fluoride reduced Rt during a 30-min incubation period, and again there was no 
significant further decrease over the subsequent 3 h (one-way ANOVA with Tukey’s post-
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hoc test; P≥0.05). In mouse epithelia treated with fluoride (n= 5), transepithelial resistance 
was lower than in control epithelia (n=2). Rt for fluoride-treated epithelia was significantly 
lower at all time points than Rt for control epithelia (P<0.0001). 
 
Proteomic Analysis 
Caco-2 cell monolayers were either untreated (control) or exposed to 5 mM fluoride for 24 h. 
Comparative analysis showed 5 and 103 proteins up- and down-regulated, respectively, in the 
fluoride-treated group compared with control [Table SI]. The numbers of proteins exclusively 
expressed in the control and fluoride-treated groups were 229 [Table SII] and 113 [Table 
SIII], respectively. GO analysis showed that proteins with altered expression were most 
commonly related to the “homophilic cell adhesion via plasma membrane adhesion 
molecules” term, with a 14% frequency. In addition, 8% of the proteins were related to 
“response to unfolded protein”, while 7% were related to “pyridine-containing compound 
metabolic process”. Exposure to fluoride changed the expression of various proteins related 
to cell motility and adhesion. The expression of proteins related to actin binding, such as 
various isoforms of alpha-actinin was increased, while the expression of various isoforms of 
tubulin and actin was decreased. In addition, some proteins related to cell-matrix and cell-cell 
adhesion were uniquely identified in the group exposed to fluoride, such as integrin beta-4 
fragment (J3KSH9), while others were uniquely identified in the control group, such as 
vinculin (P18206) and multiple isoforms of protocadherin. Furthermore, exposure to fluoride 
reduced the expression of various proteins related to different steps of protein synthesis and 
folding, as depicted in the sub-network shown in Figure 6, where many proteins with altered 
expression interacted with SNW domain-containing protein 1 (Q13573), which is involved in 
transcriptional regulation. Among the interacting proteins are 78 kDa glucose-regulated 
protein (GRP78; P11021) and elongation factor 1-alpha 1 (P68104), which were down-
regulated by fluoride, and 116 kDa U5 small nuclear ribonucleoprotein component (Q15029) 
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and nuclear receptor corepressor 2 (Q9Y618), which were absent after exposure to fluoride. 
Other proteins related to folding that were also reduced in sub-network are endoplasmin 
(P14625), down-regulated by fluoride and T-complex protein 1 subunit beta (P78371) absent 
upon exposure to fluoride. 
 
DISCUSSION 
We have investigated the effects of fluoride on three types of intestinal epithelium: Caco-2 
cell monolayers, and rat and mouse colonic epithelia. We found that fluoride reduced 
forskolin-stimulated Isc and Rt in all three epithelia. In Caco-2 cell monolayers, these 
functional effects of fluoride were accompanied by perturbations of the morphology of tight 
junctions between the cells, as revealed by both scanning electron microscopy and anti-ZO-1 
immunofluorescence. In this context, our finding that the expression of alpha-actinin-4 (P 
O43707) was increased upon exposure to fluoride is interesting. This protein is involved in 
tight junction assembly in epithelial cells probably through interaction with MICALL2; 
specifically, it links MICALL2 to the actin cytoskeleton and recruits it to tight junctions 
(UNIPROT). 
 The Caco-2 adenocarcinoma cell line forms monolayers that are of similar morphology 
to native enterocytes (Hidalgo et al., 1989), and polymerase chain reaction analysis has 
shown that transporter expression is similar to that in the small intestine (Maubon et al., 
2007). In our experiments, fluoride reduced forskolin-stimulated Isc and Rt over identical 
concentration ranges (IC50, 3.1 mM). Hence, the Caco-2 cell monolayers are considerably 
less sensitive to fluoride than M-1 mouse kidney cortical collecting duct epithelia, in which 
both Isc and Rt are reduced to zero at 1 mM fluoride (IC50, 300 M; Antonio et al., 2017). 
Although its molecular basis is unclear and the first insights into this aspect have only been 
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recently reported (Melo et al., 2017), this difference might reflect the fact that the intestinal 
epithelium is the first barrier encountered by ingested fluoride. 
 Interestingly, while we found that both Isc and Rt in Caco-2 cell monolayers were reduced 
to zero at 5 mM fluoride, others have shown that cell viability is unaffected by fluoride at 
concentrations up to 5.2 mM (Rocha et al., 2013). This discrepancy suggests that changes in 
transepithelial ion transport and resistance are particularly sensitive cytotoxic effects that are 
manifest before cell viability is compromised (Narai et al., 1997). In support of this 
suggestion, Wang et al. (2001) found a diminished Rt in endothelial cells exposed to 20 mM 
NaF after 10 min, despite cell viability assays indicating no cytotoxicity at 2 h. The fact that 
forskolin-stimulated Isc and Rt were equally sensitive to fluoride suggest that the two effects 
have a common cause. The observed effects on tight junction morphology could account for 
the reduced Rt, which in turn would reduce the electrogenic ion transport across the 
epithelium, thereby explaining the reduction in Isc. 
 Various intracellular targets of fluoride have been identified in previous studies. There 
have been several reports of effects on the cytoskeleton; for example, endothelial cells 
exposed to fluoride undergo contraction and increased intercellular separation (similar to the 
effect observed in the present study), which coincides with increased myosin light chain 
phosphorylation (Wang et al., 2001). However, the fact that fluoride did not affect cell 
stiffness in our experiments would appear to rule out a significant effect on the cytoskeleton 
of Caco-2 cells. A 24-h exposure to fluoride (2.1-8.4 mM) induced DNA damage and 
cytotoxicity in human embryo hepatocytes (Wang et al., 2004). Further, in human oral 
mucosal fibroblasts, fluoride caused ATP depletion, disturbed protein synthesis and 
diminished mitochondrial function in a concentration-dependent manner above 4 mM (Jeng 
et al., 1998). The observed reduction in the number or amount of proteins identified upon 
treatment with fluoride suggests that protein synthesis and folding had been adversely 
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affected [Tables SI-SIII, Fig. 6]. Fluoride may also directly inhibit ion transport through 
effects on the Na
+
/K
+
-ATPase (Murphy and Hoover, 1992), or a reduction in intracellular 
ATP levels, as seen in macrophages at physiologically relevant plasma fluoride 
concentrations (Gutowska et al., 2010). In the present study, expression of two isoforms of 
ATP synthase was reduced upon exposure to fluoride [Table SI]. Numerous intestinal 
epithelial transporters can be modulated via phosphorylation (Barrett and Keely, 2000); 
hence, the known actions of fluoride on cellular phosphatases and kinases, either direct or via 
intracellular pathways, could result in altered ionic transport. It has been reported, for 
instance, that fluoride can inhibit renal phosphatases at micromolar levels (Partanen, 2002), 
and exert effects on G-protein signaling, protein kinases A and C, and tyrosine kinase in 
human lung epithelial cells (Refsnes et al., 2003).  
 Current World Health Organization guidelines (2006) recommend water fluoride levels 
of 1.5 mg/L (~80 μM), which is significantly lower than the concentrations producing effects 
in our experiments. The highest groundwater fluoride level observed in India, 48 mg/L (2.5 
mM; Fawell et al., 2006), approaches our IC50 in Caco-2 cell monolayers, but any meaningful 
comparison would have to be based on the assumption that the epithelium would be directly 
exposed to the imbibed fluid. The fact that 5 mM fluoride had similar effects on rat and 
mouse colonic epithelia to those on Caco-2 cell monolayers suggests that the results obtained 
with the intestinal cell line are relevant to the behavior of intestinal epithelia in vivo. On the 
other hand, we need to recognize that our experiments involved only exposure to fluoride for 
a maximum of 72 h, raising the possibility that our results may not be directly applicable to 
the situation where people are exposed chronically to low-levels of fluoride in drinking water.  
 In conclusion, our results show that fluoride exposure induces changes in the structure, 
function and proteome of intestinal epithelia, but only at concentrations higher than those 
likely to be encountered under normal circumstances. 
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Fig. 1. Effect of fluoride on the function of Caco-2 cell monolayers. (A) Representative 
response to forskolin, added at the asterisk. Transepithelial resistance (Rt) was measured via 
changes in Isc during 5-s pulses to a 2-mV transepithelial voltage every 30 s. (B) Relationship 
between forskolin-stimulated Isc and fluoride concentration. Bars show SEM (n=4-14). The 
dashed line shows the IC50 value. (C) Relationship between Rt and fluoride concentration. 
Bars show SEM (n=4-14). The dashed line shows the IC50 value. (D) Time-course of the 
effect of fluoride on Rt. Bars show SEM (n=3-15). 
 
Fig. 2. Effect of fluoride treatment on epithelial structure. Representative scanning electron 
micrographs of the apical surface of a control epithelium (A) and an epithelium treated for 48 
h with 5 mM fluoride (B). Scale bars, 5 m. 
 
Fig. 3. Effect of fluoride on tight junction integrity. Immunofluorescence images showing the 
distribution of ZO-1 in a control epithelium (A) and in an epithelium treated for 48 h with 5 
mM fluoride (B). Arrows indicate areas enclosed by ZO-1 that contain more than one nucleus. 
Scale bar, 50 m. 
 
Fig. 4. Effect of fluoride on the function of rat colonic epithelia. (A) Representative 
cumulative concentration-response data for forskolin acting on a control rat colonic 
epithelium. Amiloride (10
-5
 M) was added at the arrowhead to block ENaC. Increasing 
concentrations of forskolin (10
-7
 M, 3 x 10
-7
 M, 10
-6
 M, 3 x 10
-6
 M and 10
-5
 M) were then 
added at the asterisks. Finally, furosemide (10
-4
 M) was added at the circle to block NKCC1. 
Transepithelial resistance (Rt) was measured via changes in Isc during 5-s pulses to a 2-mV 
transepithelial voltage every 30 s. Time scale bar, 10 min. (B) Representative cumulative 
concentration-response data for forskolin acting on a rat colonic epithelium that had been pre-
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treated with fluoride for 30 min. Drugs were added as in (A). Time scale bar, 10 min. (C) 
Relationship between Isc and the concentration of forskolin in control (circles; n=11) and 
fluoride-treated (5 mM; squares; n=12) epithelia. Bars show SEM. Data were fitted to a 4-
parameter logistic equation. Asterisks indicate a significant difference between control and 
fluoride (two-way ANOVA with Bonferroni’s post-hoc test: ***, P<0.001; ****, P<0.0001). 
(D) Time-course of the effect of fluoride on Rt. Data are shown for control (circles; n=2) and 
fluoride-treated (5 mM; squares; n=6) epithelia. Bars show SEM. Asterisks indicate a 
significant difference between control and fluoride (two-way ANOVA with Bonferroni’s 
post-hoc test: **, P<0.01; ****, P<0.0001). 
 
Fig. 5. Effect of fluoride on the function of mouse colonic epithelia. (A) Relationship 
between Isc and forskolin concentration in control (circles; n=31) and fluoride-treated (5 mM; 
squares; n=12) epithelia. Bars show SEM. Data were fitted to a 4-parameter logistic equation. 
Asterisks indicate a significant difference between control and fluoride (two-way ANOVA 
with Bonferroni’s post-hoc test, ***P < 0.001, ****P < 0.0001). (B) Time-course of the 
effect of fluoride on Rt. Data are shown for control (diamonds; n=2) and fluoride-treated (5 
mM; squares; n=5) epithelia. Bars show SEM. Asterisks indicate a significant difference 
between control and fluoride (two-way ANOVA with Bonferroni’s post-hoc test: **, P<0.01; 
****, P<0.0001). 
 
 Fig. 6. Subnetwork created by ClusterMark® to establish the interaction between proteins in 
Caco-2 cells identified as having differential expression in the fluoride-treated group 
compared with control. The color of the nodes indicates the differential expression of each 
protein, with its access code. The dark red nodes indicate proteins unique to the control. The 
nodes in gray indicate the interacting proteins predicted by CYTOSCAPE®, which were not 
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identified in the present study. The light red nodes indicate proteins downregulated in the 
fluoride-treated group. According to the UNIPROT data base, the proteins illustrated are: 
P78371: T-complex protein 1 subunit beta; Q5VW00: DDB1- and CUL4-associated factor 
12-like protein 2; Q9Y618: Nuclear receptor corepressor 2; Q15029: 116 kDa U5 small 
nuclear ribonucleoprotein component; P06733: Alpha-enolase; P11021: 78 kDa glucose-
regulated protein; P14625: Endoplasmin; P07437: Tubulin beta chain; P68104: Elongation 
factor 1-alpha 1; P68133: Actin, alpha skeletal muscle; O43823: A-kinase anchor protein 8; 
O15379: Histone deacetylase 3; O95503: Chromobox protein homolog 6; O94905: Erlin-2; 
Q13573: SNW domain-containing protein 1; Q96D17: tRNA pseudouridine(38/39) synthase; 
Q01534: Testis-specific Y-encoded protein 1; P17020: Zinc finger protein 16. 
 






 Table SI. Proteins with significant changes in expression in Caco-2 cells treated with 5 mM fluoride 
compared with control group.  
 
Accession Gene Description 
PLGS 
score 
     Ratio   
(F:control) 
H7C5W8 ACTN1 Alpha-actinin-1 (Fragment)  139.78 3.71 
P06748 NPM1 Nucleophosmin  214.84 1.65 
O43707 ACTN4 Alpha-actinin-4  160.85 1.40 
P12814 ACTN1 Alpha-actinin-1  155.07 1.36 
P05787 KRT8 Keratin. type II cytoskeletal 8  102.01 1.16 
E9PNX1 SERPINH1 Serpin H1 (Fragment)  302.27 0.94 
P06576 ATP5B ATP synthase subunit beta, mitochondrial  294.93 0.73 
P25705 ATP5A1 ATP synthase subunit alpha, mitochondrial  1135.13 0.66 
Q14974 KPNB1 Importin subunit beta-1  77.39 0.64 
P04350 TUBB4A Tubulin beta-4A chain  203.76 0.64 
D6RBL5 ANXA5 Annexin  129.84 0.63 
Q9NY65 TUBA8 Tubulin alpha-8 chain  75.7 0.59 
Q13748 TUBA3C Tubulin alpha-3C/D chain  75.7 0.59 
Q6PEY2 TUBA3E Tubulin alpha-3E 97.19 0.59 
P68366 TUBA4A Tubulin alpha-4A chain  75.7 0.59 
H3BUX2 CYB5B Cytochrome b5 type B  290.73 0.58 
H7BZJ3 PDIA3 Protein disulfide-isomerase A3 (Fragment) 343.91 0.58 
O43169 CYB5B Cytochrome b5 type B  290.73 0.58 
Q71U36 TUBA1A Tubulin alpha-1A chain 5341.14 0.58 
D6RFH4 CYB5B Cytochrome b5 type B  290.73 0.58 
Q9BQE3 TUBA1C Tubulin alpha-1C chain  5341.14 0.58 
P08758 ANXA5 Annexin A5  347.24 0.58 
E9PHT9 ANXA5 Annexin  315.4 0.57 
P68363 TUBA1B Tubulin alpha-1B chain  5341.14 0.57 
P14625 HSP90B1 Endoplasmin  324.98 0.54 
J3KNF8 CYB5B Cytochrome b5 type B  290.73 0.54 
A0A087X2E9 GSTP1 Glutathione S-transferase P (Fragment) 600.61 0.54 
P10809 HSPD1 60 kDa heat shock protein, mitochondrial  1750.41 0.53 
Q15084 PDIA6 Protein disulfide-isomerase A6  101.95 0.53 
P07900 HSP90AA1 Heat shock protein HSP 90-alpha  551.7 0.52 
P0C221 CCDC175 Coiled-coil domain-containing protein 175  75.97 0.52 
O00299 CLIC1 Chloride intracellular channel protein 1  210.21 0.51 
A8K7Q2 HSPA8 Heat shock cognate 71 kDa protein  203.82 0.51 
Q58FF7 HSP90AB3P Putative heat shock protein HSP 90-beta-3  43.05 0.51 
P32119 PRDX2 Peroxiredoxin-2  507.16 0.51 
P08238 HSP90AB1 Heat shock protein HSP 90-beta  147.59 0.50 
Q06830 PRDX1 Peroxiredoxin-1  507.16 0.50 
P40926 MDH2 Malate dehydrogenase. mitochondrial  407.79 0.49 
P30101 PDIA3 Protein disulfide-isomerase A3  162.74 0.49 
Q96GW1 HSP90B1 Endoplasmin  67.13 0.48 
P11142 HSPA8 Heat shock cognate 71 kDa protein  1813.21 0.48 
P30084 ECHS1 Enoyl-CoA hydratase. mitochondrial  236.87 0.47 
A0A087WVQ9 EEF1A1 Elongation factor 1-alpha 1  515.19 0.46 
A0A0G2JIW1 HSPA1B Heat shock 70 kDa protein 1B  1752.97 0.46 
P0DMV9 HSPA1B Heat shock 70 kDa protein 1B  1752.97 0.46 
P68104 EEF1A1 Elongation factor 1-alpha 1  515.19 0.46 
Q5VTE0 EEF1A1P5 Putative elongation factor 1-alpha-like 3  515.19 0.46 
P0DMV8 HSPA1A Heat shock 70 kDa protein 1A  1752.97 0.45 
E9PNE6 HSPA8 Heat shock cognate 71 kDa protein  1700.33 0.45 
J3KPS3 ALDOA Fructose-bisphosphate  355.5 0.45 
E9PKE3 HSPA8 Heat shock cognate 71 kDa protein  1785.87 0.44 
P04075 ALDOA Fructose-bisphosphate aldolase A  355.5 0.44 
P12277 CKB Creatine kinase B-type  212.43 0.44 
A8MX94 GSTP1 Glutathione S-transferase P  963.37 0.44 
P17066 HSPA6 Heat shock 70 kDa protein 6  1425.92 0.44 
G3V3R4 TUBB3 HCG1983504. isoform CRA_c  320.37 0.44 
P11021 HSPA5 78 kDa glucose-regulated protein  415.61 0.44 
P54652 HSPA2 Heat shock-related 70 kDa protein 2  1774.68 0.44 
G3V2R8 TUBB3 HCG1983504, isoform CRA_e  320.37 0.44 
G3V5W4 TUBB3 Tubulin beta-3 chain  320.37 0.44 
P09211 GSTP1 Glutathione S-transferase P  963.37 0.44 
G3V2N6 TUBB3 HCG1983504. isoform CRA_d  320.37 0.44 
Q05639 EEF1A2 Elongation factor 1-alpha 2  95.38 0.43 
P62937 PPIA Peptidyl-prolyl cis-trans isomerase A  1440.16 0.43 
P60709 ACTB Actin, cytoplasmic 1  575.04 0.43 
F5H5D3 TUBA1C Tubulin alpha-1C chain  5341.14 0.43 
P63261 ACTG1 Actin, cytoplasmic 2  575.04 0.43 
Q9BYX7 POTEKP Putative beta-actin-like protein 3  502.31 0.42 
A5A3E0 POTEKP POTE ankyrin domain family member F  502.31 0.42 
F8WE65 PPIA Peptidyl-prolyl cis-trans isomerase  1440.16 0.42 
Q13885 TUBB2A Tubulin beta-2A chain  1454.28 0.42 
P34931 HSPA1L Heat shock 70 kDa protein 1-like  1786.52 0.42 
P38646 HSPA9 Stress-70 protein, mitochondrial  854.97 0.42 
Q9BVA1 TUBB2B Tubulin beta-2B chain  1454.28 0.42 
Q562R1 ACTBL2 Beta-actin-like protein 2  507.48 0.42 
P63267 ACTG2 Actin, gamma-enteric smooth muscle  507.48 0.42 
Q6S8J3 POTEE POTE ankyrin domain family member E  502.31 0.42 
Q13509 TUBB3 Tubulin beta-3 chain  1443.49 0.41 
P48741 HSPA7 Putative heat shock 70 kDa protein 7  1404.53 0.41 
P00558 PGK1 Phosphoglycerate kinase 1  119.27 0.41 
A0A0B4J269 
 
Uncharacterized protein  1443.49 0.41 
F8VS66 TUBA1C Tubulin alpha-1C chain  5265.44 0.41 
Q5JP53 TUBB Tubulin beta chain  1454.28 0.41 
V9GZ37 HSPA1A Heat shock 70 kDa protein 1A  81.96 0.41 
P68133 ACTA1 Actin, alpha skeletal muscle  507.48 0.41 
P07437 TUBB Tubulin beta chain  1454.28 0.41 
P68032 ACTC1 Actin, alpha cardiac muscle 1  507.48 0.41 
P62736 ACTA2 Actin, aortic smooth muscle  507.48 0.41 
P13796 LCP1 Plastin-2  48.98 0.41 
H3BQN4 ALDOA Fructose-bisphosphate aldolase  355.5 0.41 
G3V2A3 TUBB3 Tubulin beta-3 chain (Fragment)  1123.12 0.41 
A0A087WUM2 LDHAL6A L-lactate dehydrogenase  80.83 0.40 
Q5ST81 TUBB Tubulin beta chain  1133.91 0.40 
P68371 TUBB4B Tubulin beta-4B chain  1326.88 0.40 
P55072 VCP Transitional endoplasmic reticulum ATPase  68.43 0.40 
P30041 PRDX6 Peroxiredoxin-6  236.73 0.39 
O60486 PLXNC1 Plexin-C1  17.18 0.39 
P00338 LDHA L-lactate dehydrogenase A chain  80.83 0.38 
Q6ZMR3 LDHAL6A L-lactate dehydrogenase A-like 6A  85.76 0.38 
Q3ZCM7 TUBB8 Tubulin beta-8 chain  203.76 0.38 
A0A075B724 TUBB8 Tubulin beta-8 chain  192.97 0.37 
P09104 ENO2 Gamma-enolase  101.14 0.37 
M0QX14 TUBB4A Tubulin beta-4A chain  192.97 0.37 
P07195 LDHB L-lactate dehydrogenase B chain  120.82 0.36 
P0CG39 POTEJ POTE ankyrin domain family member J  293.29 0.29 
P0CG38 POTEI POTE ankyrin domain family member I  286.08 0.29 
E5RIZ5 PPIA Peptidyl-prolyl cis-trans isomerase A  731.15 0.27 
C9J5S7 PPIA Peptidyl-prolyl cis-trans isomerase  1440.16 0.26 
Identified proteins are organized according to the PLGS score. Identification is based on protein 
ID from UniProt protein database (http://www.uniprot.org/). 
Table SII. Proteins identified exclusively in untreated Caco-2 cells (control). 
 
Accession Gene Description 
    PLGS     
score 
P31939 ATIC Bifunctional purine biosynthesis protein PURH  604.69 
D6R904 TPM3 Tropomyosin alpha-3 chain  426.32 
Q5HYB6 DKFZp686J1372 Epididymis luminal protein 189  426.32 
Q8NA19 L3MBTL4  Lethal(3)malignant brain tumor-like protein 4  397.51 
P13639 EEF2 Elongation factor 2  326.82 
Q15029 EFTUD2 116 kDa U5 small nuclear ribonucleoprotein component  307.44 
P06733 ENO1 Alpha-enolase  252.36 
E5RGE1 YWHAZ 14-3-3 protein zeta/delta (Fragment)  251.38 
H3BRD5 MYO9A Unconventional myosin-IXa  248.17 
B2RTY4 MYO9A Unconventional myosin-IXa  248.17 
Q5VU61 TPM3 Tropomyosin alpha-3 chain  240.83 
K7EL95 QTRT1 Queuine tRNA-ribosyltransferase (Fragment)  240.33 
J3KQ43 ALS2 Alsin (Fragment)  230.18 
H0Y8Y2 ANK2 Ankyrin-2 (Fragment)  225.34 
Q9BWD1 ACAT2 Acetyl-CoA acetyltransferase. cytosolic  219.28 
H7BYH4 SOD1 Superoxide dismutase [Cu-Zn]  216.39 
Q58EX7 PLEKHG4 Puratrophin-1  215.35 
H3BR70 PKM Pyruvate kinase  215.17 
P35579 MYH Myosin-9  214.35 
H3BQP9 PLEKHG4 Puratrophin-1 (Fragment)  212.05 
H0Y933 ANK2 Ankyrin-2 (Fragment)  202.89 
B1AH99 MYH9 Myosin-9 (Fragment)  200.43 
Q5BKV1 MYH9 MYH9 protein  200.43 
P18206 VCL  Vinculin  187.78 
H0YK48 TPM1 Tropomyosin alpha-1 chain  185.49 
J3KN67 TPM3  Tropomyosin alpha-3 chain  185.49 
P13797 PLS3 Plastin-3  182.39 
F5H0C5 PHB2 Prohibitin-2  180.6 
X6R3G6 MFGE8 Lactadherin  174.75 
P15822 HIVEP1 Zinc finger protein 40  171.73 
I3L504 EIF5A Eukaryotic translation initiation factor 5A-1  171.23 
O95994 AGR2  Anterior gradient protein 2 homolog  169.8 
A0A0A0MSQ0 PLS3 Plastin-3  168.48 
F5H212 HIVEP1 Zinc finger protein 40  168.17 
Q9UKA1 FBXL5 F-box/LRR-repeat protein 5  165.83 
Q9HC52 CBX8 Chromobox protein homolog 8  159.88 
H7C0P3 NCOR2 Nuclear receptor corepressor 2 (Fragment)  159.79 
A0A096LPE1 VCL Vinculin  159.5 
P07864 LDHC L-lactate dehydrogenase C chain  159.42 
F5H245 LDHC L-lactate dehydrogenase  159.42 
Q9UBB9 TFIP11 Tuftelin-interacting protein 11  157.39 
C9J2N3 HIVEP1 Zinc finger protein 40 (Fragment)  157.15 
Q16586 SGCA Alpha-sarcoglycan  148.07 
Q9UGJ1 TUBGCP4 Gamma-tubulin complex component 4  140.96 
F5H365 SEC23A Protein transport protein Sec23A  140.63 
F8W775 NRCAM Neuronal cell adhesion molecule  137.15 
H3BQY4 TUBGCP4 Gamma-tubulin complex component 4 (Fragment)  131.05 
A0A087X2B3 NRCAM Neuronal cell adhesion molecule  130.06 
Q9NUJ7 PLCXD1 PI-PLC X domain-containing protein 1  129.95 
C9JP92 PLCXD1 PI-PLC X domain-containing protein 1 (Fragment)  129.95 
X6RFG1 PLCXD1 PI-PLC X domain-containing protein 1 (Fragment)  129.95 
Q9BXI2 SLC25A2 Mitochondrial ornithine transporter 2  127.87 
Q9UN70 PCDHGC3 Protocadherin gamma-C3  123.77 
G3V5X8 SEC23A Protein transport protein Sec23A  121.08 
Q9Y5F6 PCDHGC5 Protocadherin gamma-C5  118.22 
F5GXQ8 SYNE1 Nesprin-1  117.96 
P35243 RCVRN Recoverin  116.92 
Q7Z3Z4 PIWIL4  Piwi-like protein 4  116.87 
Q5VW00 DCAF12L2 DDB1- and CUL4-associated factor 12-like protein 2  115.37 
Q03403 TFF2 Trefoil factor 2  115.28 
Q9Y5H1 PCDHGA2 Protocadherin gamma-A2  114.39 
P68036 UBE2L3 Ubiquitin-conjugating enzyme E2 L3  113.46 
A6NIW5 PRDX2 Peroxiredoxin 2, isoform CRA_a  111.75 
A0A0A0MRI2 SNX6 Sorting nexin 6, isoform CRA_b  111.38 
Q9UNH7 SNX6 Sorting nexin-6  111.38 
Q9Y5G2 PCDHGB2 Protocadherin gamma-B2  111.32 
Q16854 DGUOK Deoxyguanosine kinase. mitochondrial  110.51 
A0A0A0MQW1 KSR1 Protein kinase C  110.47 
Q8IVT5 KSR1 Kinase suppressor of Ras 1  110.47 
O00764 PDXK Pyridoxal kinase  110.18 
P98160 HSPG2 Basement membrane-specific heparan sulfate 
proteoglycan core protein  
108.94 
Q9Y5G1 PCDHGB3 Protocadherin gamma-B3  108.32 
Q6WCQ1 MPRIP Myosin phosphatase Rho-interacting protein   106.18 
H0YMU7 KMT2C Histone-lysine N-methyltransferase 2C  105.6 
P18615 NELFE Negative elongation factor E  105.31 
F5H422 SYNE1 Nesprin-1  103.79 
Q13315 ATM  Serine-protein kinase ATM  103.62 
F5H4Q0 SYNE1 Nesprin-1  101.21 
Q8WV37 ZNF480 Zinc finger protein 480  99.51 
Q9Y5G3 PCDHGB Protocadherin gamma-B1  99.11 
Q9Y5G0 PCDHGB5 Protocadherin gamma-B5  99.11 
A0A0U1RQT3 HSPG2 Basement membrane-specific heparan sulfate 
proteoglycan core protein (Fragment)  
99.11 
Q9BQI5 SGIP1 SH3-containing GRB2-like protein 3-interacting protein 1  98.31 
O00567 NOP56 Nucleolar protein 56  97.79 
A0A087WUC2 PCDHGC4 Protocadherin gamma-C4  97.17 
Q9Y5H4 PCDHGA1 Protocadherin gamma-A1  97.17 
Q9Y5H3 PCDHGA10 Protocadherin gamma-A10  97.17 
Q9Y5H2 PCDHGA11 Protocadherin gamma-A11  97.17 
Q9Y5H0 PCDHGA3 Protocadherin gamma-A3  97.17 
Q9Y5G9 PCDHGA4 Protocadherin gamma-A4  97.17 
Q9Y5G8 PCDHGA5 Protocadherin gamma-A5  97.17 
Q9Y5G7 PCDHGA6  Protocadherin gamma-A6  97.17 
Q9Y5G6 PCDHGA7 Protocadherin gamma-A7  97.17 
Q9Y5G5 PCDHGA8  Protocadherin gamma-A8  97.17 
Q9Y5G4 PCDHGA9  Protocadherin gamma-A9  97.17 
Q9Y5F9 PCDHGB6 Protocadherin gamma-B6  97.17 
Q9Y5F8 PCDHGB7 Protocadherin gamma-B7  97.17 
Q9Y5F7 PCDHGC4 Protocadherin gamma-C4  97.17 
Q9UN71 PCDHGB4 Protocadherin gamma-B4  97.17 
Q9BR81 PCDHGC3 Protocadherin gamma subfamily C. 3  97.17 
A0A087WT05 PCDHGA4 Protocadherin gamma-A4  97.17 
A0A087WYB5 PCDHGC3 Protocadherin gamma-C3  97.17 
O60330 PCDHGA12 Protocadherin gamma-A12  97.17 
P78371 CCT2 T-complex protein 1 subunit beta  97.14 
F5GWF6 CCT2 T-complex protein 1 subunit beta  97.14 
B9A041 MDH1 Malate dehydrogenase. cytoplasmic  95.61 
Q9BSH5 HDHD3 Haloacid dehalogenase-like hydrolase domain-containing 
protein 3  
94.33 
Q8IXJ6 SIRT2 NAD-dependent protein deacetylase sirtuin-2  94.13 
D6REN3 PSMG4 Proteasome assembly chaperone 4  93.54 
F5H116 PIWIL4 Piwi-like protein 4  91.82 
E9PD43 NELFE Negative elongation factor E (Fragment)  91.39 
G3V2U1 SNX6 Sorting nexin-6  91.38 
Q8TEW0 PARD3 Partitioning defective 3 homolog  91.36 
F6R8P8 SGIP1 SH3-containing GRB2-like protein 3-interacting protein 1 
(Fragment)  
91.1 
H7C5N6 ASIC3 Acid-sensing ion channel 3 (Fragment)  90.61 
H0YFT4 SYNE1 Nesprin-1 (Fragment)  90.51 
F8W1K6 PLXNC1 Plexin-C1  90.23 
H0YHE0 HEATR5A HEAT repeat-containing protein 5A (Fragment)  89.68 
P35613 BSG Basigin  88.52 
P38159 RBMX RNA-binding motif protein, X chromosome  88.05 
E7EUT5 GAPDH  Glyceraldehyde-3-phosphate dehydrogenase  87.3 
Q5VWU8 PARD3 Partitioning defective 3 homolog  86.75 
E9PCA1 CCT5 T-complex protein 1 subunit epsilon  85.59 
P51689 ARSD  Arylsulfatase D  84.67 
H0Y7E2 MPRIP Myosin phosphatase Rho-interacting protein (Fragment)  84.4 
Q5VWV2 PARD3 Partitioning defective 3 homolog  83.94 
P09622 DLD Dihydrolipoyl dehydrogenase. mitochondrial  82.64 
Q92954 PRG4 Proteoglycan 4  82.36 
O43615 TIMM44  Mitochondrial import inner membrane translocase subunit 
TIM44  
81.79 
G3V140 CEP57L1 Centrosomal protein CEP57L1  81.68 
Q6P2R3 C6orf182 C6orf182 protein  81.68 
F5GZI3 PARD3 Partitioning defective 3 homolog  79.32 
A0A0A0MT41 PLCXD1 PI-PLC X domain-containing protein 1 (Fragment)  78.85 
Q9H841 NIPAL2 NIPA-like protein 2  78.79 
E9PEX6 DLD Dihydrolipoyl dehydrogenase  78.72 
Q86UP8 GTF2IRD2 General transcription factor II-I repeat domain-containing 
protein 2A  
78.57 
Q6EKJ0 GTF2IRD2B General transcription factor II-I repeat domain-containing 
protein 2B  
78.57 
E5RJN3 NCAPH2 Condensin-2 complex subunit H2 (Fragment)  78.19 
H7C327 ARSD Arylsulfatase D (Fragment)  77.96 
Q5QPM2 RALY RNA-binding protein Raly (Fragment)  75.39 
Q9Y618 NCOR2  Nuclear receptor corepressor 2  74.87 
G5E977 NAPRT  Nicotinate phosphoribosyltransferase  74.87 
P41970 ELK3 ETS domain-containing protein Elk-3  74.61 
Q6IQ55 TTBK2 Tau-tubulin kinase 2  73.66 
Q5GLZ8 HERC4 Probable E3 ubiquitin-protein ligase HERC4  72.95 
H3BUY5 RBMX RNA-binding motif protein. X chromosome  72.77 
Q8N4C6 NIN Ninein  72.6 
Q5JXT2 NOP56 Nucleolar protein 56 (Fragment)  72.13 
B1AP52 PARD3 Partitioning defective 3 homolog  72 
J3QRL2 MPRIP Myosin phosphatase Rho-interacting protein (Fragment)  71.82 
H0Y8T1 SGCA Alpha-sarcoglycan (Fragment)  71.68 
P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L  70.48 
C9J066 NIN  Ninein  69.31 
M0R2S2 EPS15L1 Epidermal growth factor receptor substrate 15-like 1  69.07 
H0Y6K7 HERC4  Probable E3 ubiquitin-protein ligase HERC4 (Fragment)  69.02 
Q13439 GOLGA4 Golgin subfamily A member 4  68.25 
A6ZIE4 MUC1 MUC1 isoform M10  67.94 
A6ZIE3 MUC1 MUC1 isoform M9  67.94 
B1AVQ7 MUC1 Mucin-1  67.94 
F8WCH0 ACTG2 Actin, gamma-enteric smooth muscle  67.19 
G5E9R0 ACTB Actin, cytoplasmic 1  67.19 
F8WB63 ACTG2  Actin, gamma-enteric smooth muscle  67.19 
J3KT65 ACTG1 Actin, cytoplasmic 2  67.19 
Q9UIJ7 AK3  GTP:AMP phosphotransferase AK3, mitochondrial  67.19 
H0YM25 GOLGA6L22 Golgin subfamily A member 6-like protein 22  66.77 
O95271 TNKS Tankyrase-1  65.89 
F8VQ14 CCT2 T-complex protein 1 subunit beta  64.31 
P21549 AGXT  Serine--pyruvate aminotransferase  63.53 
Q8IZA0 KIAA0319L Dyslexia-associated protein KIAA0319-like protein  63.22 
O95613 PCNT Pericentrin  63.06 
Q12765 SCRN1 Secernin-1  62.31 
O00192 ARVCF Armadillo repeat protein deleted in velo-cardio-facial 
syndrome  
62.23 
E7EWY6 TNKS Tankyrase-1  62.2 
A0A0B4J292 TTBK2 Tau-tubulin kinase 2  61.74 
Q8TD31 CCHCR1 Coiled-coil alpha-helical rod protein  60.29 
B1AN15 KIAA0319L Dyslexia-associated protein KIAA0319-like protein 
(Fragment)  
60.1 
B4DYG9 KIAA0319L Dyslexia-associated protein KIAA0319-like protein  60.1 
H0YDE5 KIAA1549L  UPF0606 protein KIAA1549L (Fragment)  59.92 
H0YME6 KIF23 Kinesin-like protein  59.34 
Q17RN3 FAM98C Protein FAM98C  59.15 
P30520 ADSS Adenylosuccinate synthetase isozyme 2  59.08 
K7EQV0 NLRP11 NACHT, LRR and PYD domains-containing protein 11  58.44 
Q8N7Z2 GOLGA6L1 Golgin subfamily A member 6-like protein 1  58.06 
A8MZA4 GOLGA6L6 Golgin subfamily A member 6-like protein 6  58.06 
P08243 ASNS  Asparagine synthetase [glutamine-hydrolyzing]  57.22 
B8ZZP4 SCRN1 Secernin-1  56.35 
C9JJX6 ARVCF Armadillo repeat protein deleted in velo-cardio-facial 
syndrome  
55.95 
Q9BW61 DDA1 DET1- and DDB1-associated protein 1  55.36 
P54278 PMS2 Mismatch repair endonuclease PMS2  55.27 
Q14232 EIF2B1 Translation initiation factor eIF-2B subunit alpha  55.26 
P10632 CYP2C8 Cytochrome P450 2C8  55.16 
P24821 TNC Tenascin  54.66 
Q9H4A4 RNPEP Aminopeptidase B  54.59 
O15049 N4BP3  NEDD4-binding protein 3  53.76 
H3BS38 GOLGA6L2  Golgin subfamily A member 6-like protein 2  53.21 
Q53F39 MPPE1  Metallophosphoesterase 1  53.21 
Q58FF6 HSP90AB4P Putative heat shock protein HSP 90-beta 4  52.77 
Q9UPN4 CEP131 Centrosomal protein of 131 kDa  52.42 
Q5TZA2 CROCC  Rootletin  51.91 
A6NKB8 RNPEP Aminopeptidase B  51.22 
C9JHJ5 GOLGA4  Golgin subfamily A member 4 (Fragment)  50.95 
A0A0B4J1R6 TKT Transketolase  48.8 
P29401 TKT Transketolase  48.8 
K7EJ21 QTRT1  Queuine tRNA-ribosyltransferase (Fragment)  48.36 
K7ESP6 QTRT1  Queuine tRNA-ribosyltransferase (Fragment)  48.36 
I3L2X7 CEP131 Centrosomal protein of 131 kDa (Fragment)  45.01 
P46108 CRK Adapter molecule crk  43.67 
Q00341 HDLBP Vigilin  41.77 
A0A0A0MRF5 SIRT2 NAD-dependent protein deacetylase sirtuin-2  39.73 
A0A087WYM3 SIRT2 NAD-dependent protein deacetylase sirtuin-2  39.73 
E7EWX6 SIRT2 NAD-dependent protein deacetylase sirtuin-2 (Fragment)  39.73 
H0Y394 HDLBP  Vigilin (Fragment)  39.71 
A0A024R4E5 HDLBP High density lipoprotein binding protein (Vigilin). isoform 
CRA_a  
39.71 
I3L2J8 CEP131 Centrosomal protein of 131 kDa  39.32 
Q14145 KEAP1  Kelch-like ECH-associated protein 1  34.64 
A0A0G2JP78 RAD17 Cell cycle checkpoint protein RAD17  32.34 
O75943 RAD17 Cell cycle checkpoint protein RAD17  32.34 
A0A0G2JPT5 RAD17 Cell cycle checkpoint protein RAD17  32.34 
Q13127 REST RE1-silencing transcription factor  32.15 
Q01484 ANK2 Ankyrin-2  31.91 
Q3V6T2 CCDC88A Girdin  31.6 
E9PEI6 DPCR1 Diffuse panbronchiolitis critical region protein 1  26.7 
I6L894 ANK2 Ankyrin-2  26.1 
O75643 SNRNP200 U5 small nuclear ribonucleoprotein 200 kDa helicase  25.7 
A4UGR9 XIRP2 Xin actin-binding repeat-containing protein 2  24.44 
Q5HYC2 KIAA2026 Uncharacterized protein KIAA2026  24.2 
H0Y786 NEB Nebulin (Fragment)  18.28 
H0YEM4 VWA3B  von Willebrand factor A domain-containing protein 3B 
(Fragment)  
18 
Q9P2D7 DNAH1 Dynein heavy chain 1. axonemal  17.05 
Identified proteins are organized according to the PLGS score. Identification is based on 
protein ID from UniProt protein database (http://www.uniprot.org/). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table SIII. Proteins identified exclusively in fluoride-treated Caco-2 cells. 
 
Accession Gene Description 
PLGS 
score 
H0YMU9 ANXA2 Annexin  1593.78 
P07355 ANXA2 Annexin A2  1593.78 
E5RGW4 NPM1 Nucleophosmin (Fragment)  250.85 
J3KSH9 ITGB4 Integrin beta-4 (Fragment 247.77 
A0A0C4DGS6 BCAS4 Breast carcinoma-amplified sequence  237.43 
Q8TDM0 BCAS4 Breast carcinoma-amplified sequence 4  237.43 
A0A0U1RQV5 uncharacterized Uncharacterized protein (Fragment)  214.16 
Q5JYR7 RPN2 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2 (Fragment)  
193.9 
Q5JYR4 RPN2 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2 (Fragment)  
193.9 
P04844 RPN2 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2  
193.9 
W4VSR2 MPND MPN domain-containing protein  181.72 
H0YJ09 HAUS4 HAUS augmin-like complex subunit 4 (Fragment)  181.55 
Q9P253 VPS18 Vacuolar protein sorting-associated protein 18 homolog  172.92 
P13929 ENO3 Beta-enolase  172.1 
H0YMC9 VPS18 Vacuolar protein sorting-associated protein 18 homolog  164.5 
J3KTM9 KPNB1 Importin subunit beta-1 (Fragment 160.11 
J3QRG4 KPNB1 Importin subunit beta-1 (Fragment)  158.13 
F8VY02 ERP29 Endoplasmic reticulum resident protein 29  143.29 
P30040 ERP29 Endoplasmic reticulum resident protein 29  143.29 
F5H0C8 ENO2 Enolase  138.07 
F8VUW4 PLXNC1 Plexin-C1 (Fragment)  136.15 
A6NMY6 ANXA2 Putative annexin A2-like protein  132.54 
I3L391 CACNA1A 
Voltage-dependent P/Q-type calcium channel subunit 
alpha-1A (Fragment)  
109.81 
Q7Z494 NPHP3 Nephrocystin-3  108.79 
Q6DKI2 LGALS9C Galectin-9C  107.29 
Q3B8N2 LGALS9B Galectin-9B  107.29 
Q6DN72 FCRL6 Fc receptor-like protein 6  104.59 
F5GYB3 FCRL6 Fc receptor-like protein 6 (Fragment)  104.59 
Q8N5I4 vPS18 
Dehydrogenase/reductase SDR family member on 
chromosome X  
104.37 
P51571 SSR4 Translocon-associated protein subunit delta  100.78 
A0A0J9YXS1 NPHP3-ACAD11 Protein NPHP3-ACAD11 (Fragment 95.06 
A0A0A0MQU4 SCLY  Selenocysteine lyase  88.85 
Q96I15 SCLY  Selenocysteine lyase  88.85 
E9PFF5 FXR1 Fragile X mental retardation syndrome-related protein 1  87.67 
H7C4Y8 BCAS4 Breast carcinoma-amplified sequence 4  87.44 
H3BR68 ALDOA Fructose-bisphosphate aldolase A (Fragment)  87.03 
A6NMU3 STAM  Signal transducing adapter molecule 1 (Fragment)  80.12 
A1L0T0 ILVBL Acetolactate synthase-like protein  79.34 
P31150 GDI1 Rab GDP dissociation inhibitor alpha  79.19 
B4DQB2 VNN2 Vascular non-inflammatory molecule 2  76.89 
J3KQQ7 VNN2 Vascular non-inflammatory molecule 2  76.89 
J3QT03 VNN2 Vascular non-inflammatory molecule 2  76.89 
Q96RU2 USP28 Ubiquitin carboxyl-terminal hydrolase 28  74.97 
F5H0E2 SLC3A2 4F2 cell-surface antigen heavy chain (Fragment)  74.53 
Q9UHB7 AFF4 AF4/FMR2 family member 4  71.08 
F5H8A6 TNFRSF1A 
Tumor necrosis factor receptor superfamily member 1A 
(Fragment)  
71.01 
P39687 ANP32A 
Acidic leucine-rich nuclear phosphoprotein 32 family 
member A 
70.02 
Q92688 ANP32B 
Acidic leucine-rich nuclear phosphoprotein 32 family 
member B  
70.02 
C9JCE0 AFF4 AF4/FMR2 family member 4 (Fragment 68.97 
F5GZ74 USP28 Ubiquitin carboxyl-terminal hydrolase 28  66.94 
Q86YA3 ZGRF1 Protein ZGRF1  64.56 
O95197 RTN3 Reticulon-3  63.86 
Q9UHD1 CHORDC1 Cysteine and histidine-rich domain-containing protein 1  63.79 
Q8N1H7 SIX6OS1 Protein SIX6OS1  63.53 
G3XAL8 ZGRF1  HCG21296, isoform CRA_a  62.92 
Q9H6D7 HAUS4 HAUS augmin-like complex subunit 4  60.8 
B7Z4M1 RTN3 Reticulon  59.74 
Q6ZUS5 CCDC121 Coiled-coil domain-containing protein 121  58.28 
P51172 SCNN1D Amiloride-sensitive sodium channel subunit delta  58.17 
J3QR96 LGALS9C Galectin  57.64 
P07237 GN=P4HB Protein disulfide-isomerase  55.83 
P11169 GN=SLC2A3 
Solute carrier family 2. facilitated glucose transporter 
member 3  
55.66 
O94761 RECQL4 ATP-dependent DNA helicase Q4  55.4 
G5E9G6 TRIP12 E3 ubiquitin-protein ligase TRIP12  54.38 
E9PS00 FADS3 Fatty acid desaturase 3  52.72 
O14772 FPGT Fucose-1-phosphate guanylyltransferase  50.8 
D6REN9 ZGRF1 Protein ZGRF1 (Fragment)  49.88 
O00182 LGALS9 Galectin-9  49.65 
Q96S94 CCNL2 Cyclin-L2  48.94 
F8W876 MASP1 Mannan-binding lectin serine protease 1  48.48 
G3V1X1 ZFC3H1 Proline/serine-rich coiled-coil 2. isoform CRA_a  47.82 
Q9H813 TMEM206 Transmembrane protein 206  46.94 
P30048 PRDX3 Thioredoxin-dependent peroxide reductase, mitochondrial  46.62 
Q96KP4 CNDP2 Cytosolic non-specific dipeptidase  46.07 
A0A087X072 RECQL4 ATP-dependent DNA helicase Q4  45.85 
Q4G0X0 DMD DMD protein  45.36 
A0A0C4DGR2 PTOV1 Prostate tumor overexpressed gene 1. isoform CRA_d 45.05 
P05062 ALDOB Fructose-bisphosphate aldolase B  44.56 
Q9Y6N5 SQRDL Sulfide:quinone oxidoreductase. mitochondrial  44.15 
K7EIL6 uncharacterized Uncharacterized protein (Fragment)  43.8 
K7ESL4 RAD51D DNA repair protein RAD51 homolog 4  43.8 
Q86XW9 NME9 Thioredoxin domain-containing protein 6  43.45 
P54257 HAP1 Huntingtin-associated protein 1  42.61 
Q16352 INA  Alpha-internexin  42.26 
Q96T88 UHRF1 E3 ubiquitin-protein ligase UHRF1  42.07 
Q8TDB8 SLC2A14 
Solute carrier family 2. facilitated glucose transporter 
member 14  
40.63 
O94989 ARHGEF15 Rho guanine nucleotide exchange factor 15  40.44 
A0A087X0B9 PTPRQ Phosphatidylinositol phosphatase PTPRQ  39.86 
A0A087WZU1 PTPRQ Phosphatidylinositol phosphatase PTPRQ  39.86 
Q96P48 ARAP1 
Arf-GAP with Rho-GAP domain. ANK repeat and PH 
domain-containing protein 1  
39.54 
A1A4Y4 IRGM Immunity-related GTPase family M protein  38.35 
A0A087WTJ0 RECQL4 ATP-dependent DNA helicase Q4 (Fragment)  38.16 
O43426 SYNJ1 Synaptojanin-1  37.8 
Q14BN4 SLMAP Sarcolemmal membrane-associated protein  37.58 
P13489 RNH1 Ribonuclease inhibitor  36.97 
Q4KMQ1 TPRN  Taperin  36.3 
A0A0J9YYG8 DLG5 Disks large homolog 5 (Fragment)  35.03 
Q9C0H5 ARHGAP39  Rho GTPase-activating protein 39  34.19 
Q9P2E2 KIF17 Kinesin-like protein KIF17  33.08 
Q01546 KRT76 Keratin. type II cytoskeletal 2 oral  32.85 
O95936 EOMES Eomesodermin homolog  32.42 
Q86VW1 SLC22A16 Solute carrier family 22 member 16  32.27 
H0Y3F1 SCNN1D 
Amiloride-sensitive sodium channel subunit delta 
(Fragment 
32.09 
Q9UJV3 MID2 Probable E3 ubiquitin-protein ligase MID2  31.99 
Q6ZMY3 SPOCD1 SPOC domain-containing protein 1  29.75 
Q5XKE5 KRT79 Keratin, type II cytoskeletal 79  27.42 
P12035 KRT3 Keratin, type II cytoskeletal 3  27.42 
Q9UBT2 UBA2 SUMO-activating enzyme subunit 2  25.08 
Q8NDM7 CFAP43 Cilia- and flagella-associated protein 43  20.5 
Q99728 BARD1 BRCA1-associated RING domain protein 1  19.8 
E9PPM7 SPOCD1 SPOC domain-containing protein 1  18.83 
Q14693 LPIN1 Phosphatidate phosphatase LPIN1  18.83 
H0Y390 MACF1 
Microtubule-actin cross-linking factor 1. isoforms 1/2/3/5 
(Fragment)  
11.09 
Identified proteins are organized according to the PLGS score. Identification is based on 
protein ID from UniProt protein database (http://www.uniprot.org/). 
 
